Papua New Guinea vs Trinidad and Tobago: Treatment success rate for patients treated for MDR-TB
Papua New Guinea
33.0%
in 2022
Trinidad and Tobago
33.0%
in 2020
Papua New Guinea rank
151st
Trinidad and Tobago rank
151st
Treatment success rate for patients treated for MDR-TB over time
- Papua New Guinea
- Trinidad and Tobago
How they compare
Papua New Guinea currently reports 33.0% against 33.0% in Trinidad and Tobago, a difference of 0.0%.
Across all 5 years both countries report, Papua New Guinea has been ahead every year.
Papua New Guinea ranks 151st and Trinidad and Tobago ranks 151st of 163 countries.
Papua New Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 63.5% | 12.5% | 51.0% | Papua New Guinea |
| 2020s | 72.0% | 33.0% | 39.0% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Papua New Guinea or Trinidad and Tobago?
- Papua New Guinea, at 33.0% against 33.0% in Trinidad and Tobago as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Papua New Guinea and Trinidad and Tobago?
- 0.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Trinidad and Tobago?
- 5 years are reported by both, from 2014 to 2020.
- How do Papua New Guinea and Trinidad and Tobago rank globally for treatment success rate for patients treated for mdr-tb?
- Papua New Guinea ranks 151st and Trinidad and Tobago ranks 151st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.